You are here: Industry Insights > Shire

News List

Takeda reaches preliminary agreement to acquire Shire firstwordpharma
April 25, 2018
Shire said Wednesday that it would "be willing to recommend" that shareholders accept Takeda's revised offer, which is valued at 46 billion pounds ($65 billion).
Takeda eyes Shire, will it be 2018’s biggest deal? biospectrumasia
April 25, 2018
Japan’s Takeda in negotiations to acquire Irish drugmaker Shire, a global rare disease drug giant. A successful acquisition will generate a global pharmaceutical powerhouse worth over $80bn with $30 bn in annual sales.
Takeda Pharma and Shire Come Back to the Negotiating Table biospace
April 25, 2018
Takeda Pharmaceutical has come back with an improved bid for Shire, making it the fifth round of talks.
Takeda woos Shire shareholders with increased bid pharmaphorum
April 24, 2018
Takeda has sweetened its offer for Shire, increasing its bid slightly and improving its terms to win over the UK-listed firm’s shareholders after a string of rejections.
Allergan says not interested in buying Shire pharmaphorum
April 23, 2018
Allergan has said it is not interested in buying Shire after all, after announcing yesterday that it was considering a bid for the UK-listed firm also targeted by Takeda.
Takeda Comes Back to the Table, Shire Acquisition Bid Continues to Twist and Turn biospace
April 23, 2018
Takeda Pharmaceutical has come back to the bargaining table with a juicier bid for Shire
Shire Rejects Takeda’s $60 Billion Acquisition Bid and Allergan Reportedly In Talks with Shire biospace
April 20, 2018
According to Reuters UK, Takeda Pharmaceutical has made an official bid to acquire London’s Shire for about $60 billion. And in breaking news, Shire rejected the bid, saying it undervalued the company.
Shire drives awareness on hemophilia in APAC biospectrumasia
April 19, 2018
Optimal care of patients with haemophilia, and management of prophylactic factor replacement therapy, however is complex and requires a multidisciplinary team approach through a specialised HTC and includes psychosocial support.
Shire offloads its oncology business for $2.4B biospectrumasia
April 18, 2018
Shires said that the deal will help increase its focus on rare diseases
Shire offloads its oncology business for $2.4B biospectrumasia
April 17, 2018
Shires said that the deal will help increase its focus on rare diseases

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page